Ferulamide
CAS No. 61012-31-5
Ferulamide ( 4-Hydroxy-3-methoxycinnamide )
Catalog No. M29143 CAS No. 61012-31-5
Ferulamide, a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 410 | Get Quote |
|
10MG | 602 | Get Quote |
|
25MG | 945 | Get Quote |
|
50MG | 1278 | Get Quote |
|
100MG | 1728 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFerulamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionFerulamide, a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation.
-
DescriptionFerulamide, a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation.(In Vitro):A series of Ferulamide derivatives were prepared and evaluated for their anti-platelet activities. Some of these compounds showed potent inhibitory activity against arachidonic acid-induced platelet aggregation. Their structure-activity relationships are also discussed.
-
Synonyms4-Hydroxy-3-methoxycinnamide
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number61012-31-5
-
Formula Weight193.2
-
Molecular FormulaC10H11NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc(cc(/C=C/C(N)=O)cc1)c1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Cochinchinenin A
Cochinchinenin A is the material basis for the analgesic effect of Dragons Blood.
-
Vasonatrin Peptide V...
Vasonatrin peptide (VNP) is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) with potent venodilating and natriuretic activity.
-
DBT
DBT is a far-red/near-infrared fluorescent probe for specific in vitro and in vivo imaging of tumor-associated proteins.